Ildong Pharmaceutical Revenue

Ildong Pharmaceutical had revenue of 145.46B KRW in the quarter ending September 30, 2025, a decrease of -6.73%. This brings the company's revenue in the last twelve months to 575.66B, down -5.67% year-over-year. In the year 2024, Ildong Pharmaceutical had annual revenue of 614.94B with 2.36% growth.

Revenue (ttm)

575.66B

Revenue Growth

-5.67%

P/S Ratio

2.08

Revenue / Employee

542.56M

Employees

1,061

Market Cap

1.20T

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	614.94B	14.18B	2.36%
Dec 31, 2023	600.76B	-36.96B	-5.80%
Dec 31, 2022	637.71B	77.58B	13.85%
Dec 31, 2021	560.13B	-1.71B	-0.30%
Dec 31, 2020	561.85B	44.38B	8.58%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Daewoong	2.06T
GC Biopharma	1.93T
Chong Kun Dang Pharmaceutical	1.68T
Daewoong Pharmaceutical	1.54T
Dong-A Socio Holdings	1.40T
Boryung	1.03T
DongKook Pharmaceutical	894.93B
Huons Global	825.44B

Revenue Rankings